epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aklief
    trifarotene topical
  • remove Cardura
    doxazosin
  • remove Ninjacof-D
    pyrilamine/ chlophedianol/ pseudoephedrine

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Cardura (doxazosin) + Ninjacof-D (pyrilamine/ chlophedianol/ pseudoephedrine)

Monitor/Modify Tx


doxazosin + pseudoephedrine

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Caution Advised


doxazosin + chlophedianol

caution advised w/ doxazosin ER dosage form: combo may incr. doxazosin levels, risk of adverse effects (absorption increased)

doxazosin + pyrilamine

caution advised w/ doxazosin ER dosage form: combo may incr. doxazosin levels, risk of adverse effects (absorption increased)

Additional Considerations

Smiley face Smiley face pseudoephedrine in Ninjacof-D

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information